Authors: | Sharma, A.; Boelens, J. J.; Cancio, M. I.; Hankins, J.; Bhad, P. A.; Lewandowski, A.; Zhao, X.; Chitnis, S.; Peddinti, R.; Zheng, Y.; Kapoor, N.; Ciceri, F.; Yuan, J.; Yu, V. W.; Stevenson, S. C.; De Vita, S.; LaBelle, J. |
Abstract Title: | Treatment of individuals with severe sickle cell disease with OTQ923, an autologous, ex vivo, CRISPR/Cas9-edited, CD34+ hematopoietic stem and progenitor cell product, leads to durable engraftment and fetal hemoglobin induction |
Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 140 |
Issue: | Suppl. 1 |
Meeting Dates: | 2022 Dec 10-13 |
Meeting Location: | New Orleans, LA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2022-11-15 |
Start Page: | 1906 |
End Page: | 1908 |
Language: | English |
ACCESSION: | WOS:000893223201372 |
DOI: | 10.1182/blood-2022-166254 |
PROVIDER: | wos |
Notes: | Meeting Abstract -- Source: Wos |